Lombard Odier Asset Management (Europe)’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,000
Closed -$392K 291
2024
Q1
$392K Hold
20,000
0.02% 213
2023
Q4
$461K Buy
20,000
+1,000
+5% +$22.4K 0.03% 215
2023
Q3
$437K Hold
19,000
0.02% 225
2023
Q2
$496K Sell
19,000
-2,000
-10% -$52.8K 0.02% 227
2023
Q1
$580K Sell
21,000
-3,000
-13% -$79.2K 0.03% 249
2022
Q4
$545K Buy
24,000
+15,000
+167% +$418K 0.02% 258
2022
Q3
$307K Buy
+9,000
New +$333K 0.02% 259

Other funds holding PRVA

Lombard Odier Asset Management (Europe)'s PRVA Position: Q2 2024 in Review

Lombard Odier Asset Management (Europe) sold out of Privia Health (PRVA) in Q2 2024, closing a stake of 20,000 shares — an estimated $392K sold.

Lombard Odier Asset Management (Europe) first reported a position in PRVA in Q3 2022 and held it in 7 quarters. The position peaked at $580K in Q1 2023. 225 funds tracked by Wall St. Rank hold PRVA as of Q2 2024.

  • Lombard Odier Asset Management (Europe) reported no remaining Privia Health position as of Q2 2024 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 20,000 Privia Health shares in Q2 2024, an estimated $392K.
  • Lombard Odier Asset Management (Europe) first reported a position in Privia Health in Q3 2022 and held it in 7 quarters.
  • Lombard Odier Asset Management (Europe)'s Privia Health position peaked at $580K in Q1 2023.
  • 225 funds tracked by Wall St. Rank held Privia Health as of Q2 2024.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2024, filed 14 Aug 2024.